Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

BDSX

Biodesix (BDSX)

Biodesix Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:BDSX
DataHoraFonteTítuloCódigoCompanhia
03/03/202518:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BDSXBiodesix Inc
03/03/202518:01GlobeNewswire Inc.Biodesix Announces Fourth Quarter and Fiscal Year 2024 ResultsNASDAQ:BDSXBiodesix Inc
26/02/202518:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BDSXBiodesix Inc
26/02/202508:00GlobeNewswire Inc.Biodesix to Present at TD Cowen 45th Annual Health Care ConferenceNASDAQ:BDSXBiodesix Inc
18/02/202508:00GlobeNewswire Inc.Biodesix to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025NASDAQ:BDSXBiodesix Inc
11/02/202518:41Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BDSXBiodesix Inc
07/02/202518:08Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:BDSXBiodesix Inc
10/01/202508:00GlobeNewswire Inc.Biodesix Announces Preliminary Fourth Quarter and Full-Year 2024 Results (Unaudited)NASDAQ:BDSXBiodesix Inc
07/01/202508:00GlobeNewswire Inc.Biodesix Announces Publication of a New Nodify CDT® Clinical Validation StudyNASDAQ:BDSXBiodesix Inc
13/11/202409:30Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:BDSXBiodesix Inc
13/11/202402:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:BDSXBiodesix Inc
12/11/202418:25Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:BDSXBiodesix Inc
12/11/202418:23Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:BDSXBiodesix Inc
01/11/202408:12Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:BDSXBiodesix Inc
01/11/202407:08Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BDSXBiodesix Inc
01/11/202407:00GlobeNewswire Inc.Biodesix Announces Third Quarter 2024 Results and HighlightsNASDAQ:BDSXBiodesix Inc
29/10/202407:00GlobeNewswire Inc.Biodesix to Participate in Three Investor Conferences in NovemberNASDAQ:BDSXBiodesix Inc
18/10/202407:00Business WireBiodesix to Report Third Quarter 2024 Financial Results on November 1, 2024NASDAQ:BDSXBiodesix Inc
07/10/202407:00Business WireBiodesix Announces New Data Presentation at CHEST 2024 Annual Meeting and the Launch of a Complementary Clinical StudyNASDAQ:BDSXBiodesix Inc
05/09/202407:00Business WireBiodesix to Present at Two Investor Conferences in SeptemberNASDAQ:BDSXBiodesix Inc
07/08/202417:01Business WireBiodesix Announces Second Quarter 2024 Results and HighlightsNASDAQ:BDSXBiodesix Inc
06/08/202407:00Business WireBiodesix to Present at Canaccord Genuity’s 44th Annual Growth ConferenceNASDAQ:BDSXBiodesix Inc
24/07/202407:00Business WireBiodesix to Report Second Quarter 2024 Financial Results on August 7, 2024NASDAQ:BDSXBiodesix Inc
18/06/202409:13Business WireBiodesix Named to Inc. Magazine’s 2024 “Best Workplaces”NASDAQ:BDSXBiodesix Inc
28/05/202407:00Business WireBiodesix to Participate in Two Investor Conferences in JuneNASDAQ:BDSXBiodesix Inc
24/05/202417:11Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:BDSXBiodesix Inc
23/05/202420:09Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:BDSXBiodesix Inc
21/05/202407:00Business WireBiodesix to Present New Data on the Nodify XL2® Test at ATS 2024 Annual MeetingNASDAQ:BDSXBiodesix Inc
08/05/202417:01Business WireBiodesix Announces First Quarter 2024 Results Driven by Growth in Lung Diagnostic Testing for Lung Nodule ManagementNASDAQ:BDSXBiodesix Inc
07/05/202407:00Business WireBiodesix to Participate in the 2024 RBCCM Global Healthcare ConferenceNASDAQ:BDSXBiodesix Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:BDSX